Rankings
▼
Calendar
RGEN FY 2015 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
FY 2015 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$84M
+31.5% YoY
Gross Profit
$48M
57.8% margin
Operating Income
$14M
16.5% margin
Net Income
$9M
11.2% margin
EPS (Diluted)
$0.28
Cash Flow
Operating Cash Flow
$15M
Free Cash Flow
$12M
Stock-Based Comp.
$4M
Balance Sheet
Total Assets
$146M
Total Liabilities
$23M
Stockholders' Equity
$123M
Cash & Equivalents
$73M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$84M
$64M
+31.5%
Gross Profit
$48M
$36M
+35.9%
Operating Income
$14M
$11M
+28.7%
Net Income
$9M
$8M
+14.4%
← FY 2014
All Quarters
Q1 2016 →